242 related articles for article (PubMed ID: 10935898)
1. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.
Burgess K; Moore A; Rand W; Cotter SM
J Vet Intern Med; 2000; 14(4):456-62. PubMed ID: 10935898
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
Reimer ME; Troy GC; Warnick LD
J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
[TBL] [Abstract][Full Text] [Related]
3. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).
Grundy SA; Barton C
J Am Vet Med Assoc; 2001 Feb; 218(4):543-6. PubMed ID: 11229506
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial.
Mason N; Duval D; Shofer FS; Giger U
J Vet Intern Med; 2003; 17(2):206-12. PubMed ID: 12683622
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
[TBL] [Abstract][Full Text] [Related]
7. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
Balch A; Mackin A
Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
[TBL] [Abstract][Full Text] [Related]
8. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
Gerber B; Steger A; Hässig M; Glaus TM
Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
[TBL] [Abstract][Full Text] [Related]
9. Serial monitoring of clinical, haematological and immunological parameters in canine autoimmune haemolytic anaemia.
Day MJ
J Small Anim Pract; 1996 Nov; 37(11):523-34. PubMed ID: 8934425
[TBL] [Abstract][Full Text] [Related]
10. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
Weingart C; Thielemann D; Kohn B
Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
Piek CJ; van Spil WE; Junius G; Dekker A
BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
Al-Ghazlat S
Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
West LD; Hart JR
J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
[TBL] [Abstract][Full Text] [Related]
15. Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs.
Kellerman DL; Bruyette DS
J Vet Intern Med; 1997; 11(6):327-32. PubMed ID: 9470156
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
Scott-Moncrieff C
J Am Anim Hosp Assoc; 2001; 37(1):11. PubMed ID: 11204471
[No Abstract] [Full Text] [Related]
17. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
Elwood C; Polton G
J Vet Intern Med; 2008; 22(5):1075. PubMed ID: 18844828
[No Abstract] [Full Text] [Related]
18. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
Swann JW; Skelly BJ
J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia].
Griebsch C; Arndt G; Kohn B
Berl Munch Tierarztl Wochenschr; 2010; 123(3-4):160-8. PubMed ID: 20329649
[TBL] [Abstract][Full Text] [Related]
20. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
